ArticleJournal of kidney cancer and VHL2026
Double Trouble: Renal Collision Tumors with Unexpected Histology-A Case Report with Review of Literature.
Article in Journal of kidney cancer and VHL, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary Non-Hodgkin's Lymphoma (NHL) involving the adrenal gland is rare, and its synchronous occurrence with renal cell carcinoma (RCC) is exceedingly uncommon. Although adrenal involvement is observed in approximately 20% of systemic NHL cases, primary adrenal lymphoma accounts for only a small proportion of these cases. RCC accounts for 2-3% of all malignancies and is the second most common genitourinary cancer. The coexistence of RCC with other primary malignancies has been described, often in the context of familial syndromes; however, its synchronous presentation with primary adrenal NHL is exceptionally rare. A 54-year-old male with diabetes presented with intermittent dull left flank pain for 18 months and a recent loss of appetite. Contrast-enhanced computed tomography revealed a large, heterogeneous, hyper-enhancing mass in the left suprarenal region replacing the adrenal gland, along with a separate enhancing exophytic lesion in the left kidney. Positron emission tomography showed high metabolic activity in both lesions and regional lymph nodes. The patient underwent open radical nephrectomy with adrenalectomy and regional lymph node dissection. Histopathology demonstrated diffuse large B-cell lymphoma involving the adrenal gland with extension into the kidney, perinephric tissue, and perihilar fat, along with a separate Grade II clear cell RCC in the lower pole of the kidney. Immunohistochemistry confirmed B-cell lineage lymphoma. Lymph nodes were negative for metastasis. The patient received nine cycles of CHOP (Cyclophosphamide, Doxorubicin [Hydroxydaunorubicin], Vincristine [Oncovin], and Prednisolone) chemotherapy and remains recurrence-free at the 6-month follow-up. This case highlights a rare synchronous occurrence of primary adrenal NHL and ipsilateral clear cell RCC. Shared genetic or immunological mechanisms may underlie this association, warranting further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.